Objective To establish an economic value added(EVA)performance evaluation system to maintain the competitiveness of pharmaceutical company A under the environment of fierce competition in the pharmaceutical industry.M...Objective To establish an economic value added(EVA)performance evaluation system to maintain the competitiveness of pharmaceutical company A under the environment of fierce competition in the pharmaceutical industry.Methods An EVA performance evaluation model was established by adjusting the items of EVA performance evaluation index,such as after-tax profits,total invested capital and weighted average cost of capital rate.Results and Conclusion EVA values of pharmaceutical company A from 2014 to 2018 were calculated and compared with the traditional performance evaluation method,it was found that EVA performance evaluation model reflected the real performance of pharmaceutical company A.Therefore,pharmaceutical company A is doing well,but its growth rate is unstable.展开更多
作为先进的价值管理理念和方法的经济增加值(Economic Value Added,EVA),它不但是衡量企业业绩的重要指标,而且也是有效的财务管理系统和薪酬激励制度。以中国沪深股市2007～2009年14家上市银行的财务数据为研究样本,对其经营绩效进行测...作为先进的价值管理理念和方法的经济增加值(Economic Value Added,EVA),它不但是衡量企业业绩的重要指标,而且也是有效的财务管理系统和薪酬激励制度。以中国沪深股市2007～2009年14家上市银行的财务数据为研究样本,对其经营绩效进行测算,并从资产总额、银行资产管理水平、资本充足率和不良贷款率等视角来探索EVA的驱动因素。研究结论显示,股份制银行的绩效创造能力总体上是比较强的,而国有银行绩效创造能力处于中等偏上的水平。银行资产管理水平的控制、不良贷款率的降低和资产规模的扩大是EVA绩效的主要驱动因素,而资本充足率对EVA的促进作用并不明显。展开更多
文摘Objective To establish an economic value added(EVA)performance evaluation system to maintain the competitiveness of pharmaceutical company A under the environment of fierce competition in the pharmaceutical industry.Methods An EVA performance evaluation model was established by adjusting the items of EVA performance evaluation index,such as after-tax profits,total invested capital and weighted average cost of capital rate.Results and Conclusion EVA values of pharmaceutical company A from 2014 to 2018 were calculated and compared with the traditional performance evaluation method,it was found that EVA performance evaluation model reflected the real performance of pharmaceutical company A.Therefore,pharmaceutical company A is doing well,but its growth rate is unstable.
文摘作为先进的价值管理理念和方法的经济增加值(Economic Value Added,EVA),它不但是衡量企业业绩的重要指标,而且也是有效的财务管理系统和薪酬激励制度。以中国沪深股市2007～2009年14家上市银行的财务数据为研究样本,对其经营绩效进行测算,并从资产总额、银行资产管理水平、资本充足率和不良贷款率等视角来探索EVA的驱动因素。研究结论显示,股份制银行的绩效创造能力总体上是比较强的,而国有银行绩效创造能力处于中等偏上的水平。银行资产管理水平的控制、不良贷款率的降低和资产规模的扩大是EVA绩效的主要驱动因素,而资本充足率对EVA的促进作用并不明显。
